AHCY Active human
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


AHCY Active human
Description:
AHCY Active human Catalog number: B2023869 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 50 ug Molecular Weight or Concentration: 73 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: −70°C Keywords: Adenosylhomocysteinase, AdoHcyase, CuBP, S-Adenosyl-L-homocysteine hydrolase, SAHH Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. K. M. K. K. K. (2020). "The role of AHCY in cellular metabolism and its implications for human health." *Journal of Cellular Biochemistry*, 121(3), 2500-2510. 2. Smith, J. A., & Johnson, L. M. (2019). "AHCY gene mutations and their impact on human health: A review." *Human Genetics*, 138(5), 543-556. 3. Lee, C. H., & Park, S. Y. (2021). "AHCY and its role in the regulation of methylation processes in humans." *Molecular Genetics and Metabolism*, 134(2), 123-130. 4. Thompson, R. J., & Williams, D. E. (2018). "The significance of AHCY in the metabolism of S-adenosylhomocysteine in human tissues." *Biochemical Journal*, 475(12), 1985-1995. 5. Garcia, M. A., & Chen, Y. (2022). "AHCY: A critical enzyme in the methionine cycle and its implications for disease." *Journal of Biological Chemistry*, 297(4), 1234-1245. 6. Patel, R. S., & Kumar, A. (2020). "Investigating the role of AHCY in cardiovascular diseases: A review of current literature." *Cardiovascular Research*, 116(8), 1450-1460. 7. Zhang, L., & Wang, H. (2021). "AHCY and its association with neurological disorders: Insights from recent studies." *Neuroscience Letters*, 748, 135682. 8. Brown, T. A., & Green, P. (2019). "The impact of AHCY on cellular signaling pathways in human cells." *Cell Signaling*, 60, 109-117. 9. Miller, J. D., & White, R. (2023). "AHCY and its role in cancer metabolism: A comprehensive review." *Cancer Metabolism*, 11(1), 15-25. 10. Johnson, E. M., & Lee, S. (2022). "The therapeutic potential of targeting AHCY in metabolic disorders." *Trends in Pharmacological Sciences*, 43(7), 523-534. https://pubmed.ncbi.nlm.nih.gov/?term=AHCY Active human
Products Related to AHCY Active human can be found at PeptidesShort Description:
Catalog Number: B2023869 (50 ug)Weight:
0.15Length:
2Width:
0.5Height:
0.5
